Mereo BioPharma Group PLC (MREO)
3.72
+0.04
(+1.09%)
USD |
NASDAQ |
Nov 22, 16:00
3.725
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Free Cash Flow: -30.90M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -30.90M |
| June 30, 2024 | -20.72M |
| Date | Value |
|---|---|
| March 31, 2024 | -20.58M |
| December 31, 2023 | -21.55M |
Free Cash Flow Range, Past 5 Years
-30.90M
Minimum
Sep 2024
-20.58M
Maximum
Mar 2024
-23.44M
Average
-21.14M
Median
Free Cash Flow Benchmarks
| TC BioPharm (Holdings) PLC | -15.84M |
| NuCana PLC | -22.00M |
| Biodexa Pharmaceuticals PLC | -11.12M |
| Adaptimmune Therapeutics PLC | -56.05M |
| DBV Technologies SA | -108.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.519M |
| Cash from Financing (Quarterly) | -0.594M |
| Free Cash Flow Per Share (Quarterly) | -0.0488 |
| Free Cash Flow Yield | -5.76% |